Lamisil®
Lamisil® has been associated with serious hepatic toxicity, including liver failure and death, including some cases involving patients who had neither pre-existing liver disease nor a serious underlying medical condition.As of April 2001, the FDA is aware of 16 cases of liver failure in association with Lamisil® Tablet use (including 11 deaths and two liver transplantations). These patients received Lamisil® Tablets for the treatment of various dermatologic conditions, including onychomycosis.
Source: fda.gov
If you or a loved one has been harmed by Lamisil®, you may want to contact a Lamisil® attorney for more information.Attorney Search
Find a Defective Drug Attorney
Defective Drugs
News Alert
We will email you a news alert when Defective Drugs news article appears online.
Defective Drugs Questions
If you or a loved one has suffered harm as a result of the dangerous side effects associated with a defective drug, contact a qualified attorney today.